Efficacy of omega-3 in the treatment of polycystic ovary syndrome

References

• Azziz R, Kashar-Miller MD. 2000. Family history as a risk factor for the polycystic ovary syndrome. Journal of Pediatric Endocrinology and Metabolism 13:1303–1306.
   PubMed Web of Science ®Google Scholar
• Batukan C, Muderris II. 2006. Efficacy of a new oral contraceptive containing drospirenone and ethinyl estradiol in the long-term treatment of hirsutism. Fertility and Sterility 85:436–440.
   PubMed Web of Science ®Google Scholar
• Cancelas J, Prieto PG, Villanueva-Peñacarrillo ML, Zhang Y, Portois L, Sener A . 2007. Glucose intolerance associated to insulin resistance and increased insulin secretion in rats depleted in long-chain omega3 fatty acids. Hormone and Metabolic Research 39:823–825.
   PubMed Web of Science ®Google Scholar
• Carmina E, Orio F, Palomba S, Cascella T, Longo RA, Colao AM . 2005. Evidence for altered adipocyte function in polycystic ovary syndrome. European Journal of Endocrinology 152:389–394.
   PubMed Web of Science ®Google Scholar
• Crosignani PG, Colombo M, Vegetti W, Somigliana E, Gessati A, Ragni G. 2003. Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet. Human Reproduction 18:1928–1932.
   PubMed Web of Science ®Google Scholar
• Dandona P, Aljada A, O’Donnell A, Dhindsa S, Garg R. 2004. Insulin Is an Anti-inflammatory and Anti-atherosclerotic Hormone. Metabolic Syndrome and Related Disorders 2:137–142.
   PubMed Web of Science ®Google Scholar
• Delarue J, LeFoll C, Corporeau C, Lucas D. 2004. N-3 long chain polyunsaturated fatty acids: a nutritional tool to prevent insulin resistance associated to type 2 diabetes and obesity?Reproduction, Nutrition, Development 44:289–299.
   PubMedGoogle Scholar
• Dunaif A. 1994. Polycystic ovary syndrome. Current Therapy in Endocrinology and Metabolism 5:222–229.
   PubMedGoogle Scholar
• Dunaif A. 1997. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrine Reviews 18:774–800.
   PubMed Web of Science ®Google Scholar
• Hatch R, Rosenfield RL, Kim MH, Tredway D. 1981. Hirsutism: implications, etiology, and management. American Journal of Obstetrics and Gynecology 140:815–830.
   PubMed Web of Science ®Google Scholar
• Hauner H, Bender M, Haastert B, Hube F. 1998. Plasma concentrations of soluble TNF-alpha receptors in obese subjects. International Journal of Obesity and Related Metabolic Disorders 22:1239–1243.
   PubMed Web of Science ®Google Scholar
• Holte J, Bergh T, Berne C, Wide L, Lithell H. 1995. Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 80:2586–2593.
   PubMed Web of Science ®Google Scholar
• Kasim-Karakas SE, Almario RU, Gregory L, Wong R, Todd H, Lasley BL. 2004. Metabolic and endocrine effects of a polyunsaturated fatty acid-rich diet in polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 89:615–620.
   PubMed Web of Science ®Google Scholar
• Lewandowski KC, Szosland K, O’Callaghan C, Tan BK, Randeva HS, Lewinski A. 2005. Adiponectin and resistin serum levels in women with polycystic ovary syndrome during oral glucose tolerance test: a significant reciprocal correlation between adiponectin and resistin independent of insulin resistance indices. Molecular Genetics and Metabolism 85:61–69.
   PubMed Web of Science ®Google Scholar
• Lombardo YB, Chicco AG. 2006. Effects of dietary polyunsaturated n-3 fatty acids on dyslipidemia and insulin resistance in rodents and humans. A review. Journal of Nutritional Biochemistry 17:1–13.
   PubMed Web of Science ®Google Scholar
• Nestler JE, Powers LP, Matt DW, Steingold KA, Plymate SR, Rittmaster RS . 1991. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 72:83–89.
   PubMed Web of Science ®Google Scholar
• Olszanecka-Glinianowicz M, Zahorska-Markiewicz B, Zurakowski A, Glinianowicz M. 2005. The role of tumor necrosis factor (TNF-alpha) in control of metabolism. Wiadomosci Lekarskie 58:670–674.
   PubMedGoogle Scholar
• Panidis D, Farmakiotis D, Rousso D, Koliakos G, Kaltsas T, Krassas G. 2005. Decrease in adiponectin levels in women with polycystic ovary syndrome after an oral glucose tolerance test. Fertility and Sterility 83:232–234.
   PubMed Web of Science ®Google Scholar
• Panidis D, Kourtis A, Farmakiotis D, Mouslech T, Rousso D, Koliakos G. 2003. Serum adiponectin levels in women with polycystic ovary syndrome. Human Reproduction 18:1790–1796.
   PubMed Web of Science ®Google Scholar
• Pérez-Matute P, Pérez-Echarri N, Martínez JA, Marti A, Moreno-Aliaga MJ. 2007. Eicosapentaenoic acid actions on adiposity and insulin resistance in control and high-fat-fed rats: role of apoptosis, adiponectin and tumour necrosis factor-alpha. British Journal of Nutrition 97:389–398.
   PubMed Web of Science ®Google Scholar
• Puder J, Pralong F. 2009. Polycystic ovary syndrome and insulin resistance. Revue Medicale Suisse 5:779–782.
   PubMedGoogle Scholar
• Rotterdam ESHRE/ASRM-sponsored Consensus Workshop Group. 2004. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction 19:41–47.
   PubMed Web of Science ®Google Scholar
• Tsilchorozidou T, Overton C, Conway GS. 2004. The pathophysiology of polycystic ovary syndrome. Clinical Endocrinology 60:1–17.
   PubMed Web of Science ®Google Scholar
• Ukkola O. 2002. Resistin – a mediator of obesity-associated insulin resistance or an innocent bystander?European Journal of Endocrinology 147:571–574.
   PubMed Web of Science ®Google Scholar